All articles by Praveen Duddu

  1. Report: Favourable market environment to drive Australian pharmaceutical industry to $25bn by 2020

    Good market access and government’s welfare reforms such as subsidies for prescription drugs are expected to drive the pharmaceutical market…
    Read More…

    22 Sep
  2. Deals this week: Bayer AG, Plasticell, Sarepta Therapeutics

    Bayer AG and Evotec AG have entered a multi-target research partnership agreement to develop novel treatments for chronic kidney disease…
    Read More…

    22 Sep
  3. M&As this week: Allergan, Walvax Biotechnology

    Allergan plans to develop novel treatments for non-alcoholic steatohepatitis (NASH) and other liver diseases through the acquisition of Akarna Therapeutics….
    Read More…

    22 Sep
  4. Report: Asia-Pacific gastric cancer market to grow to $2.7bn by 2022, but prospects weak for premium pricing

    Increasing prevalence of the disease coupled with growing awareness is set to grow the market for gastric cancer in Asia-Pacific…
    Read More…

    15 Sep
  5. Report: Philippines pharmaceutical market to grow at CAGR of 3.7% to reach $4.1bn by 2020

    The Philippines pharmaceutical market is projected to rise moderately from $3.4bn in 2015 to $4.1bn by 2020 at a compound…
    Read More…

    8 Sep
  6. Report: Global diabetes and obesity therapeutics market to double by 2022

    The global market for diabetes mellitus and obesity is forecast to increase from $70.8bn in 2015 to $163.2bn by 2022,…
    Read More…

    1 Sep
  7. M&As this week: Sichuan Kelun Pharmaceutical Co. and Avantor Performance Materials

    Sichuan Kelun Pharmaceutical Co. has announced plans to acquire the remaining 15% stake in Zhejiang-based pharmaceutical unit for ¥65.3m ($9.78m)….
    Read More…

    1 Sep
  8. Report: Unmet need for safer anti-arrhythmic drugs in atrial fibrillation market to continue through to 2025

    Unavailability of safer anti-arrhythmic drugs is expected to be major issue in the atrial fibrillation market, according to a new…
    Read More…

    25 Aug
  9. M&As this week: Mallinckrodt, Scintilla Pharmaceuticals, Lonza Group

    Mallinckrodt plc has announced plans to acquire Stratatech Corporation, a regenerative medicine company that develops proprietary skin substitute products. The…
    Read More…

    18 Aug
  10. Report: Turkish pharmaceutical industry to reach $5.53bn in value by 2020

    Turkey’s pharmaceutical industry is set to grow from $5bn in 2015 to $5.53bn by 2020, at a compound annual growth…
    Read More…

    18 Aug
Close
Close
Close

Go Top